We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
-9.48%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+398.7%
AUM
$116B
AUM Growth
-$22.1B
(-16%)
Cap. Flow
+$6B
Cap. Flow
% of AUM
5.18%
Top 10 Holdings %
Top 10 Hldgs %
17.41%
Holding
4,413
New
281
Increased
1,595
Reduced
1,871
Closed
461
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares China Large-Cap ETF
FXI
|
+$473M |
| 2 |
AGN
Allergan plc
AGN
|
+$384M |
| 3 |
Linde
LIN
|
+$332M |
| 4 |
McKesson
MCK
|
+$329M |
| 5 |
Broadcom
AVGO
|
+$300M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 2 |
AT&T
T
|
+$525M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$373M |
| 4 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$285M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$269M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.9% |
| 2 | Healthcare | 12.82% |
| 3 | Financials | 9.51% |
| 4 | Consumer Discretionary | 7.09% |
| 5 | Communication Services | 6.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TECX
2976
Tectonic Therapeutic
TECX
$606M
| $535K | ﹤0.01% |
2,863
+1,720
| +150% | +$405K |
|
|
DENN
2977
DELISTED
Denny's
DENN
| $533K | ﹤0.01% |
69,383
-32,576
| -32% | -$553K |
|
2978
ProShares Ultra S&P500
SSO
$8.36B
| $533K | ﹤0.01% |
48,008
-432
| -0.9% | -$7.3K |
|
|
PGTI
2979
DELISTED
PGT, Inc.
PGTI
| $533K | ﹤0.01% |
63,507
+7,750
| +14% | +$110K |
|
2980
NatWest
NWG
$76.4B
| $532K | ﹤0.01% |
+181,388
| New | +$954K |
|
|
RAD
2981
DELISTED
Rite Aid Corporation
RAD
| $530K | ﹤0.01% |
35,314
-25,329
| -42% | -$354K |
|
2982
Andersons Inc
ANDE
$2.22B
| $528K | ﹤0.01% |
28,173
+1,441
| +5% | +$30.4K |
|
|
SVM
2983
Silvercorp Metals
SVM
$2.53B
| $525K | ﹤0.01% |
160,856
-101,185
| -39% | -$430K |
|
|
DRNA
2984
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $525K | ﹤0.01% |
28,603
-44,570
| -61% | -$866K |
|
|
HSKA
2985
DELISTED
Heska Corp
HSKA
| $525K | ﹤0.01% |
9,488
+2,215
| +30% | +$201K |
|
2986
First Trust Consumer Discretionary AlphaDEX Fund
FXD
$276M
| $524K | ﹤0.01% |
19,499
-32,344
| -62% | -$1.28M |
|
|
ENDP
2987
DELISTED
Endo International plc
ENDP
| $524K | ﹤0.01% |
141,822
-2,083
| -1% | -$10.6K |
|
2988
Travere Therapeutics
TVTX
$5.78B
| $523K | ﹤0.01% |
35,814
-5,972
| -14% | -$89.9K |
|
|
MSGN
2989
DELISTED
MSG Networks Inc.
MSGN
| $523K | ﹤0.01% |
51,367
-31,302
| -38% | -$447K |
|
|
BPFH
2990
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $521K | ﹤0.01% |
73,015
+1,887
| +3% | +$19.4K |
|
2991
Argan
AGX
$8.37B
| $520K | ﹤0.01% |
15,040
+1,194
| +9% | +$49.5K |
|
2992
State Street SPDR S&P Homebuilders ETF
XHB
$1.56B
| $520K | ﹤0.01% |
17,445
-204,316
| -92% | -$8.72M |
|
|
LGF.B
2993
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $520K | ﹤0.01% |
93,072
+8,060
| +9% | +$67.3K |
|
|
MCHB
2994
Mechanics Bancorp
MCHB
$3.68B
| $519K | ﹤0.01% |
23,341
-4,103
| -15% | -$119K |
|
|
EBSB
2995
DELISTED
Meridian Bancorp, Inc.
EBSB
| $519K | ﹤0.01% |
46,283
+1,016
| +2% | +$16.8K |
|
2996
Levi Strauss
LEVI
$9.39B
| $517K | ﹤0.01% |
41,568
-11,776
| -22% | -$208K |
|
2997
TORM
TRMD
$3.02B
| $517K | ﹤0.01% |
68,310
+21,040
| +45% | +$179K |
|
2998
ePlus
PLUS
$2.34B
| $515K | ﹤0.01% |
16,450
-4,698
| -22% | -$179K |
|
|
RAVN
2999
DELISTED
Raven Industries Inc
RAVN
| $515K | ﹤0.01% |
24,230
-2,439
| -9% | -$71.5K |
|
3000
Precigen
PGEN
$2.59B
| $513K | ﹤0.01% |
151,042
+57,871
| +62% | +$250K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q1 2020 Portfolio in Review
As of Q1 2020, Credit Suisse held 4,413 positions worth $116B, down 16% from $138B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Credit Suisse deployed $6B of net new capital in Q1 2020, opening 281 new positions and adding to 1,595 existing holdings. Its largest new stake was iShares US Healthcare Providers ETF: 4,155,000 shares worth $139M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $995M trimmed.
- Credit Suisse's largest Q1 2020 buy was iShares US Healthcare Providers ETF: 4,155,000 shares worth $139M.
- Credit Suisse added most to iShares China Large-Cap ETF in Q1 2020, an estimated $473M increase.
- Credit Suisse's biggest Q1 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $995M.
- Credit Suisse fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $285M.
- Credit Suisse's ten largest holdings make up 17% of its $116B portfolio in Q1 2020.
- Credit Suisse opened 281 new positions and closed 461 in Q1 2020.
- Credit Suisse's portfolio value fell 16% quarter-over-quarter to $116B.
Based on Credit Suisse's 13F filing for Q1 2020, filed 13 May 2020.